Monday, July 18, 2016

BRIEF-Cynapsus announces positive phase 3 results for Parkinson's drug

* New drug application for CTH-300 and CTH-301 with FDA

expected to be submitted in first half of 2017.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)